fda warning compounding semaglutide september 2025 π¨ Moves to Permanently Shut Down Compounded GLP-1s The FDA is taking steps to eliminate large-scale of GLP-1 medications like and tirzepatide, signaling a major shift in how these Diabetes advocacy group discourages use
Description
Always discuss off-label use risks and benefits with your provider

Exenatide and liraglutide have slightly better weight and efficacy outcomes compared to other GLP-1RA

Introduction GLP1 medications like semaglutide and tirzepatide are powerful tools for weight loss, but achieving the best results goes beyond medication alone

Speaking with a doctor who understands how to assess skin changes in the context of your full health picture is also helpful
